ALNYLAM PHARMACEUTICALS INC - NOTE 1.000% 9/1

Historical Portfolio Holders from Q3 2023 to Q3 2024

All holders as of September 30, 2024: Q3 2024
Type / Class: Debt / NOTE 1.000% 9/1
Principal, excl. options Q3 2024: 904M
Holdings value Q3 2024: $1.06B
Value change Q3 2024: -$27.9M
Grand Portfolio weight change Q3 2024: 0%
Number of holders: 57
Number of buys Q3 2024: 23
Number of sells Q3 2024: -37
Average buys Q3 2024 %: +0%
Average sells Q3 2024 %: -0.001%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Principal	Value	Change	Price	Investors
2024 Q3	$904M	$1.06B	-$27.9M	$1.17	57
2024 Q2	$905M	$978M	-$105M	$1.08	64
2024 Q1	$885M	$835M	+$37.6M	$0.94	67
2023 Q4	$852M	$845M	+$21.2M	$0.99	65
2023 Q3	$847M	$790M	+$790M	$0.93	54